Employing magnetic resonance histology for precision chronic limb-threatening ischemia treatment planning
Journal of Vascular Surgery · 2025
DOI: 10.1016/j.jvs.2024.08.054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vascular Surgery, 2025. Verfasst von Judit Csore und 6 weiteren Autor:innen. Beteiligte Einrichtung: DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, TX; Heart and Vascular Center, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Ischemia, Peripheral Arterial Disease, Magnetic Resonance Imaging, Endovascular Procedures. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American Heart Association-American Stroke Association, NHLBI NIH HHS, American Heart Association Inc.
Abstract (Originalsprache)
OBJECTIVE: Recent randomized controlled trials have demonstrated a notable prevalence of immediate technical failures in percutaneous vascular interventions (PVIs) for complex arterial lesions associated with chronic limb-threatening ischemia. Current imaging modalities present inherent limitations in identifying these lesions, making it challenging to determine the most suitable candidates for PVI. We present a novel preprocedural magnetic resonance imaging (MRI) histology protocol for identifying lesions that might present a higher rate of immediate and midterm PVI failure. METHODS: We enrolled 22 patients (13 females, average age 65.8 ± 9.72 years) scheduled for PVI were prospectively and underwent 3T MRI using ultrashort echo time and steady-state free precession contrasts to characterize target lesions before PVI. Lesions were scored as hard if >50% of the lumen was occluded by hard components (calcium/dense collagen) on MRI in the hardest cross-section. Two readers evaluated MRI datasets. Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease (TASC)/Global Limb Anatomic Staging System (GLASS)/Wound, Ischemia and Foot infection scoring was performed based on intraprocedural angiograms and chart review. The relationship between MRI scoring, TASC/GLASS scoring, and procedural outcomes was investigated using univariate analysis. Midterm follow-up (revascularization and amputation rates) was recorded at 3 and 6 months after the intervention. RESULTS: Our cohort of 22 patients yielded 40 target lesions. Five lesions were excluded (two for nondiagnostic image quality; three PVIs were ultimately diagnostic only). Six lesions (17%) were scored as hard. MRI-scored hard lesions had a higher proportion of immediate technical failure (hard vs soft 83% [5/6] vs 3% [1/29]; P < .001). Hard vs soft MRI scoring was the only factor significantly associated with immediate PVI technical success (P < .001), as opposed to TASC/GLASS scoring. Both at 3 months and 6 months after PVI, the reintervention rate was significantly higher among those lesions which were scored hard on MRI (3 months hard, 80% vs soft, 16% [P =.011]; 6 months hard, 80% vs soft, 27%; P = .047). CONCLUSIONS: MRI histology could be a valuable tool for optimizing PVI patient selection and treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, TX; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
- DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, TX.
- MRI Core, Translational Imaging Center, Houston Methodist Research Institute, Houston, TX.
- DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, TX. Electronic address: troy@houstonmethodist.org.
Förderung
- American Heart Association-American Stroke Association
- NHLBI NIH HHS
- American Heart Association Inc
- National Institutes of Health
- Jerold B Katz Foundation
Zitieren
APA
Csore, J., Drake, M., Karmonik, C., Benfor, B., Osztrogonacz, P., Lumsden, A. B., & Roy, T. L. (2025). Employing magnetic resonance histology for precision chronic limb-threatening ischemia treatment planning. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2024.08.054
Vancouver
Csore J, Drake M, Karmonik C, Benfor B, Osztrogonacz P, Lumsden AB, et al. Employing magnetic resonance histology for precision chronic limb-threatening ischemia treatment planning. Journal of Vascular Surgery. 2025. doi:10.1016/j.jvs.2024.08.054
BibTeX
@article{Csore2025,
author = {Csore, Judit and Drake, Madeline and Karmonik, Christof and Benfor, Bright and Osztrogonacz, Peter and Lumsden, Alan B and Roy, Trisha L},
title = {Employing magnetic resonance histology for precision chronic limb-threatening ischemia treatment planning},
journal = {Journal of Vascular Surgery},
year = {2025},
doi = {10.1016/j.jvs.2024.08.054}
}
EUVIMED